1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Genomic instability as a determinant of immune escape in ovarian cancer
    Meeting Abstract

    Vazquez-Garcia, I.; Uhlitz, F.; Ceglia, N.; Lim, J.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E.; Soslow, R.; Ellenson, L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205
    Meeting Abstract

    Lorusso, D.; Vergote, I.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; van Nieuwenhuysen, E.; Iglesias, D. A.; Collins, D.; Cibula, D.; Madsen, K.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Exploiting SMARCA2 dependency for targeted therapy in SMARCA4-deficient ovarian cancers
    Meeting Abstract

    Brodeur, M.; Dopeso, H.; Green, H.; Ito, K.; Hulse, M.; Brown, J.; Weigelt, B.; Zamarin, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: Results from the SORAYA Study
    Meeting Abstract

    Coleman, R. L.; Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Phase 2 results of relacorilant + nabpaclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U.; Oaknin, A.; Grisham, R.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H.; Lorusso, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer - Going to the next level: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Kahn, R.; McMinn, E.; Boerner, T.; Roche, K. L.; Zivanovic, O.; Gardner, G.; Sonoda, Y.; O'Cearbhaill, R.; Grisham, R.; Huang, J.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Updated safety of lenvatinib + pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/KEYNOTE-775
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Monk, B.; Mackay, H.; Santin, A.; Miller, D.; Moore, R.; Ray-Coquard, I.; Shapira-Frommer, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study
    Meeting Abstract

    Gien, L.; Enserro, D.; Block, M.; Waggoner, S.; Duska, L.; Hendrickson, A. W.; Thaker, P.; Backes, F.; Bottsford-Miller, J.; Muller, C.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save